Long non‐coding RNA HCG11 sponging miR ‐522‐3p inhibits the tumorigenesis of non‐small cell lung cancer by upregulating SOCS5

Gang Fan,Jin Jiao,Feng Shen,Qingxia Ren,Qing Wang,Fulu Chu
DOI: https://doi.org/10.1111/1759-7714.13624
IF: 3.223
2020-08-26
Thoracic Cancer
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Numerous studies have shown that long non‐coding RNA (lncRNA) is involved in various human diseases including non‐small cell lung cancer (NSCLC). The aim of this study was to explore the potential role of lncRNA HCG11 in the pathogenesis of NSCLC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The mRNA expression of HCG11, miR‐522‐3p and SOCS5 was detected by RT‐qPCR. The regulatory mechanism of lncRNA HCG11 was investigated by CCK‐8, transwell and dual luciferase reporter assays.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Downregulation of lncRNA HCG11 and upregulation of miR‐522‐3p were found in NSCLC tissues and cells, and abnormal expressions of lncRNA HCG11 and miR‐522‐3p were related to adverse clinical outcomes of NSCLC patients. LncRNA HCG11 acted as a molecular sponge for miR‐522‐3p. Functionally, lncRNA HCG11 inhibited cell viability, migration and invasion in NSCLC by downregulating miR‐522‐3p. Further, miR‐522‐3p directly targeted SOCS5. lncRNA HCG11 could positively regulate SOCS5 expression in NSCLC. In addition, HCG11 downregulation or miR‐522‐3p overexpression abolished the inhibitory effect of SOCS5 on cell viability, migration and invasion in NSCLC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>LncRNA HCG11 inhibits cell viability, migration and invasion in NSCLC by functioning as a ceRNA of miR‐522‐3p to upregulate SOCS5.</p></section>
oncology,respiratory system
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the potential role and mechanism of long non - coding RNA HCG11 in the occurrence and development of non - small - cell lung cancer (NSCLC). Specifically, the research aims to reveal the mechanism by which HCG11 affects the tumorigenesis of NSCLC and explore its potential as a therapeutic target. ### Research Background and Problem Non - small - cell lung cancer (NSCLC) is one of the leading causes of cancer - related deaths, accounting for 85% - 90% of all lung cancer cases. Despite the availability of multiple treatment methods, such as surgery, radiotherapy, chemotherapy, molecular - targeted therapy, and immunotherapy, the prognosis of NSCLC patients remains poor. Therefore, it is crucial to find effective biomarkers for early diagnosis and treatment. ### Research Objectives The main objectives of this study are: 1. To explore the expression of long non - coding RNA HCG11 in NSCLC and its relationship with clinical features. 2. To reveal the functional mechanism of HCG11 in NSCLC, especially how it inhibits tumor occurrence and development by regulating miR - 522 - 3p and SOCS5. ### Main Findings 1. **Abnormal expression of HCG11 and miR - 522 - 3p**: The study found that HCG11 was down - regulated in NSCLC tissues and cells, while miR - 522 - 3p was up - regulated. This abnormal expression was associated with poor clinical outcomes in patients. 2. **HCG11 as a molecular sponge for miR - 522 - 3p**: HCG11 exerts its tumor - suppressive effect by binding to miR - 522 - 3p and inhibiting its activity. 3. **HCG11 inhibits NSCLC progression by up - regulating SOCS5**: miR - 522 - 3p directly targets SOCS5, and HCG11 up - regulates the expression of SOCS5 by down - regulating miR - 522 - 3p, thereby inhibiting the proliferation, migration, and invasion of NSCLC cells. 4. **Functional verification**: The experimental results showed that over - expression of HCG11 could inhibit the viability and motility of NSCLC cells, and the over - expression of miR - 522 - 3p weakened this inhibitory effect. ### Conclusion This study shows that in NSCLC, HCG11 inhibits tumor occurrence and development by acting as a competing endogenous RNA (ceRNA) for miR - 522 - 3p and up - regulating the expression of SOCS5. These findings provide a new potential target for the treatment of NSCLC. ### Formula Representation The formulas involved in the paper are mainly significance tests in statistical analysis, for example: - The $\chi^2$ test was used to analyze the relationship between clinical features and the expression of lncRNA HCG11 or miR - 522 - 3p. - The Student t - test and one - way ANOVA were used to compare differences between different groups. These formulas were not listed in detail in the paper but were mentioned in the data analysis section.